Search research articles
Contact Us
Filters
Showing results (191-200 of 260) with videos related to
Page
of 26
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2020
Cerebrospinal Fluid Bacillary Load by Xpert MTB/RIF Ultra Polymerase Chain Reaction Cycle Threshold Value Predicts 2-Week Mortality in Human Immunodeficiency Virus-Associated Tuberculous Meningitis
Emily M Martyn, Ananta S Bangdiwala, Enock Kagimu, et al.
Open Forum Infectious Diseases
|
January 26, 2016
Human Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding
David R Boulware, Maximilian von Hohenberg, Melissa A Rolfes, et al.
Open Forum Infectious Diseases
|
December 18, 2020
Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
Supavit Chesdachai, Nicole W Engen, Joshua Rhein, et al.
Journal of Clinical Microbiology
|
June 5, 2020
Accuracy of Xpert Ultra in Diagnosis of Pulmonary Tuberculosis among Children in Uganda: a Substudy from the SHINE Trial
Willy Ssengooba, Jean de Dieu Iragena, Lydia Nakiyingi, et al.
Open Forum Infectious Diseases
|
September 12, 2022
Therapeutic Lumbar Punctures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?
Enock Kagimu, Nicole Engen, Kenneth Ssebambulidde, et al.
Antimicrobial Agents and Chemotherapy
|
August 5, 2020
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B
Caleb P Skipper, Mucunguzi Atukunda, Anna Stadelman, et al.
Human Immunology
|
June 14, 2026
Investigation of human leukocyte antigen alleles as risk factors for cryptococcal disease in Ugandan individuals with HIV
Caleb P Skipper, Biyue Dai, Bruno Borges, et al.
The Lancet. HIV
|
September 7, 2025
Epstein-Barr virus and cytomegalovirus co-infections and mortality risk in patients with HIV-associated cryptococcal meningitis: a post-hoc analysis of a prospective nested cohort in the AMBITION-cm randomised controlled trial
Jayne Ellis, Elisabetta Groppelli, Ronan Doyle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 24, 2024
Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort Study
Jane Gakuru, Enock Kagimu, Biyue Dai, et al.
Microbiology Spectrum
|
June 21, 2022
Diagnostic and Prognostic Value of Cerebrospinal Fluid Lactate and Glucose in HIV-Associated Tuberculosis Meningitis
Edwin Nuwagira, Kathy Huppler Hullsiek, Samuel Jjunju, et al.
Page
of 26
Search research articles
Search
Showing results (191-200 of 260) with videos related to
Sort By:
Page
of 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2020
Cerebrospinal Fluid Bacillary Load by Xpert MTB/RIF Ultra Polymerase Chain Reaction Cycle Threshold Value Predicts 2-Week Mortality in Human Immunodeficiency Virus-Associated Tuberculous Meningitis
Emily M Martyn, Ananta S Bangdiwala, Enock Kagimu, et al.
Open Forum Infectious Diseases
|
January 26, 2016
Human Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding
David R Boulware, Maximilian von Hohenberg, Melissa A Rolfes, et al.
Open Forum Infectious Diseases
|
December 18, 2020
Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
Supavit Chesdachai, Nicole W Engen, Joshua Rhein, et al.
Journal of Clinical Microbiology
|
June 5, 2020
Accuracy of Xpert Ultra in Diagnosis of Pulmonary Tuberculosis among Children in Uganda: a Substudy from the SHINE Trial
Willy Ssengooba, Jean de Dieu Iragena, Lydia Nakiyingi, et al.
Open Forum Infectious Diseases
|
September 12, 2022
Therapeutic Lumbar Punctures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?
Enock Kagimu, Nicole Engen, Kenneth Ssebambulidde, et al.
Antimicrobial Agents and Chemotherapy
|
August 5, 2020
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B
Caleb P Skipper, Mucunguzi Atukunda, Anna Stadelman, et al.
Human Immunology
|
June 14, 2026
Investigation of human leukocyte antigen alleles as risk factors for cryptococcal disease in Ugandan individuals with HIV
Caleb P Skipper, Biyue Dai, Bruno Borges, et al.
The Lancet. HIV
|
September 7, 2025
Epstein-Barr virus and cytomegalovirus co-infections and mortality risk in patients with HIV-associated cryptococcal meningitis: a post-hoc analysis of a prospective nested cohort in the AMBITION-cm randomised controlled trial
Jayne Ellis, Elisabetta Groppelli, Ronan Doyle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 24, 2024
Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort Study
Jane Gakuru, Enock Kagimu, Biyue Dai, et al.
Microbiology Spectrum
|
June 21, 2022
Diagnostic and Prognostic Value of Cerebrospinal Fluid Lactate and Glucose in HIV-Associated Tuberculosis Meningitis
Edwin Nuwagira, Kathy Huppler Hullsiek, Samuel Jjunju, et al.
Page
of 26